Virgin Group’s VG Acquisition Sets Vote Date on $3.5B 23andMe Merger

Virgin Group

 VG Acquisition set a June 10 meeting for shareholders to vote on the SPAC’s proposed merger with 23andMe, a consumer genetics company.

The transaction will value the outstanding shares of 23andMe at an aggregate enterprise value of approximately $3.5 billion. The pro forma cash balance of the combined company will exceed $900 million at closing.

If approved, 23andMe Holding Co. shares and warrants are expected to trade on the Nasdaq under ME and “ME WS, respectively.

Total
0
Shares
Related Posts
Read More

Mobix Labs Closes Business Combination with Chavant Capital 

Redemptions ahead of the meeting totaled 741,613 shares. All told, more than 99% of shares have been cashed out since the SPAC’s $80 million IPO in July 2021. Chavant last week disclosed it had added a $16.5 million PIPE of stock and warrants sold to Sage Hill Investors in support of the Mobix deal. The SPAC's sponsor was also expected to buy nearly $2 million in stock to bolster the PIPE funding.